High Assay Low Enriched Uranium (HALEU) is uranium enriched between 5% and 20% and is required for most U.S. advanced reactors designs. Currently, there is no commercial production capability for HALEU in the United States or Europe. A domestic HALEU supply chain is essential to support the commercial deployment of American-made advanced nuclear reactors.
The Nuclear Energy Institute strongly recommends that $200 million be made available for HALEU Infrastructure in FY22 appropriations to jumpstart this essential HALEU production capacity.